Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

4 Stocks Climbing This Week: ABIL, CLPS, IVTY, SPPI

Published 06/26/2018, 11:57 PM
Updated 07/09/2023, 06:31 AM

Ability Inc (NASDAQ:ABIL) jumped another 2.02, or 20%, to 12.02, on 7.3 million shares on Tuesday. This stock has now gone in four sessions from 2.21 to Tuesday’s high of 14.51, a 7-fold increase. It’s a thin stock that is trading a lot of volume, and is being manipulated, in my opinion. I would be very careful, not only because it’s up 600%, but because it’s in a resistance zone that’s going to be tough to get to without some sort of pullback. If it gets over 14.50, look for 17-18, which are the targets.

CLPS Inc (NASDAQ:CLPS) is a new issue. It rocketed from 5.00 to almost 18.00, more than tripling in a week, and then rested for three days in a falling wedge. On Tuesday, it looked like it popped out, up 1.85, or 16%, to 13.52, on 655,764 shares traded. Targets are 15 and 17, and beyond that something in the 20-22 range is possible. Keep close tabs on 11.00, because under 11.00 we’re stopping it.

Invuity Inc (NASDAQ:IVTY) broke out of a wedge on Tuesday and popped 50 cents, or 14%, to 4.00, on 544,747 shares traded. There is some resistance, but my next target has to be 4 3/4. If it gets through that, the secondary target and resistance are at 5 3/4.

Spectrum Pharmaceuticals Inc (NASDAQ:SPPI), on positive drug news, may have broken out of a big wedge on Tuesday, with a breakaway gap, on 6.4 million shares, up 2.77, or 14 1/2%, to 21.75. I like the way it looks. At this point, look for a test of 23. If it gets through 23, it has a good shot at getting to 29.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks on the long side included Ability Inc (NASDAQ:ABIL), Amyris, Inc. (AMRS), Blink Charging Co. (BLNK), Bovie Medical Corporation (BVX), CLPS Incorporation (CLPS), Endocyte, Inc. (ECYT), Enphase Energy Inc (NASDAQ:ENPH), Gray Television, Inc. (GTN), Innovate Biopharmaceuticals, Inc. (INNT), Invuity, Inc. (IVTY), SemiLEDs Corporation (LEDS), Lam Research Corporation (NASDAQ:LRCX), New York & Company Inc (NYSE:NWY), Puma Biotechnology, Inc. (PBYI), R1 RCM Inc. (RCM), Spectrum Pharmaceuticals, Inc. (SPPI), and TransEnterix, Inc. (TRXC).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.